<<

PACAP upsets theory

Stephen A. Wank

J Clin Invest. 1999;104(12):1772-1772. https://doi.org/10.1172/JCI8732E1.

Erratum

J. Clin. Invest.104:1341–1342 (1999) Notation labels for Figure 1 were moved in such a way that the figure may have been confusing to readers. The corrected figure appears below. Our apologies for the error. Figure 1Cephalic (neural) and peripheral (gastric and intestinal) endocrine and paracrine regulation of gastric . G, ; P, ; D, D cell; M cell, cell; ENS, ; GRP, -releasing ; GRPR, GRP receptor; SMS, ; VIP, vasoactive intestinal polypeptide; M, muscarinic receptor; M3, muscarinic receptor type 3; SST2, somatostatin type 2 receptor; CCKA and CCKB, type A and B receptors; Y1, PYY type 1 receptor; PYY, peptide YY; H2, type 2 receptor; Gal1, galanin type 1 receptor. Green lines indicate stimulation; red lines indicate inhibition.

Find the latest version: https://jci.me/8732E1/pdf PACAP upsets stomach theory

Stephen A. Wank

J. Clin. Invest. 104:1341–1342 (1999).

Notation labels for Figure 1 were moved in such a way that the figure may have been confusing to readers. The corrected figure appears below. Our apologies for the error.

Figure 1 Cephalic (neural) and peripheral (gastric and intestinal) endocrine and paracrine regulation of gastric acid secretion. G, G cell; P, parietal cell; D, D cell; M cell, mucus cell; ENS, enteric nervous system; GRP, gastrin-releasing peptide; GRPR, GRP receptor; SMS, somatostatin; VIP, vasoactive intestinal polypeptide; M, muscarinic receptor; M3, muscarinic receptor type 3; SST2, somatostatin type 2 receptor; CCKA and CCKB, cholecystokinin type A and B receptors; Y1, PYY type 1 receptor; PYY, peptide YY; H2, histamine type 2 receptor; Gal1, galanin type 1 receptor. Green lines indicate stimulation; red lines indi- cate inhibition.

1772 The Journal of Clinical Investigation | December 1999 | Volume 104 | Number 12